Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

uBiome Appoints Dr. Corrie Moreau, PhD, Director of the Integrative Research Center at the Field Museum of Natural History, to its Scientific Advisory Board

Ubiome
Posted on: 05 Nov 18
uBiome Appoints Dr. Corrie Moreau, PhD, Director of the Integrative Research Center at the Field Museum of Natural History, to its Scientific Advisory Board The leader in microbial genomics appoints pioneer of research in microbiology, evolution, and genomics to its board of scientific advisors.

PR Newswire

SAN FRANCISCO, Nov. 5, 2018

SAN FRANCISCO, Nov. 5, 2018 /PRNewswire-PRWeb/ -- uBiome, the leader in microbial genomics, announces the addition of Dr. Corrie Moreau, PhD, Robert A. Pritzker Director of the Integrative Research Center and Associate Curator at the Field Museum of Natural History Department of Science and Education, to its Scientific Advisory Board. Joining the board of leading scientists and doctors from around the world, Dr. Moreau will bring to uBiome expertise in the coevolution of host-associated microbes, particularly ant-associated gut bacteria. The appointment will help uBiome continue its advancement in human microbiome research.

"Not only is Dr. Moreau a brilliant researcher of host-associated microbes, but she also understands the value of citizen-science, an important component of the work we do at uBiome," Dr. Jessica Richman, PhD, co-founder and CEO of uBiome, said. "We are honored to have her on our Scientific Advisory Board."

In 2019, Dr. Moreau will take on the position of Martha N. and John C. Moser Professor of Arthropod Biosystematics and Biodiversity at Cornell University in Ithaca, New York. She is currently the Robert A. Pritzker Director of the Integrative Research Center and Associate Curator at the Field Museum of Natural History in the Department of Science and Education. She has been a Scientific Affiliate and Lecturer at the University of Chicago on the Committee on Evolutionary Biology since 2008 and was previously a Miller Fellow at the University of California Berkeley in Integrative Biology and Environmental Science, Policy and Management Departments from 2007 to 2008. The Moreau Lab researches the evolutionary history of social insects and their gut-associated microbes and uses that information to better understand the broadscale evolutionary patterns of life. In 2016, she was named a Kavli Fellow of the National Academy of Sciences; In 2015, she was named 15 Brilliant Women Bridging the Gender Gap in Science; and in 2014, 10 Women Scientists You Should Follow on Twitter. She has received funding from several federal agencies and foundations. As an advocate for scientific education and outreach, Dr. Moreau founded the Field Museum Women in Science group and seeks to engage students at all educational levels in science.

About joining uBiome's Scientific Advisory Board, Dr. Moreau said, "I am excited to join the uBiome Scientific Advisory Board to interact with an excellent group of scientists who focus on the host-associated microbiome. I am particularly interested to find ways to leverage novel technologies and microbial data to understand the microbiome of socially interacting species, which includes humans to ants. As uBiome is a leader in understanding the role and impact of the human microbiome, I hope to learn from their extensive expertise and bring my own unique perspective from working on an entirely different group of social organisms."

In addition to Dr. Moreau, the uBiome Scientific Advisory Board also includes Dr. Joseph DeRisi (MacArthur Genius and UCSF professor), Dr. Atul Butte (head of the Institute for Computational Health Sciences at UCSF), Dr. Katherine Pollard (Director, Gladstone Institute for Data Science and Biotechnology), Dr. Joel Palefsky (UCSF School of Medicine professor), Dr. George Church (leading geneticist at Harvard University), Dr. Liz Lipski (Academic Director of Nutrition and Integrative Health Programs at Maryland University of Integrative Health), Dr. Elaine Hsiao, PhD (UCLA), and other leading scientists. The company's Medical Advisory Board includes Dr. Alan Green (Society for Participatory Medicine), Dr. Leo Treyzon (Cedars-Sinai Medical Center), Dr. Cynthia Geyer (Medical Director of Canyon Ranch, Lenox), Dr. Robynne Chutkan (Georgetown University Hospital), Michael Docktor (Boston Children's Hospital), Dr. Tiffany Lester (Medical Director of Parsley Health in San Francisco), Dr. Joel Kahn (Founder of of the Kahn Center for Cardiac Longevity), as well as other accomplished clinicians.
_____

About uBiome
Founded in 2012, uBiome is the leader in microbial genomics. The Company's mission is to advance the science of the microbiome and make it useful to people. uBiome combines its patented proprietary precision sequencing™ with machine learning and artificial intelligence to develop wellness products, clinical tests, and therapeutic targets. uBiome has filed for over 250 patents on its technology, which includes sample preparation, computational analysis, molecular techniques, as well as diagnostic and therapeutic applications.

uBiome's commercial products include SmartGut™, the world's first sequencing-based clinical microbiome test, which identifies microbes in the gut for patients with chronic gut conditions such as IBD, IBS, Crohn's Disease, and ulcerative colitis; SmartJane™, the first sequencing-based women's health screening test, which genotypes all 19 clinically relevant strains of HPV, identifies four common STDs, and surveys more than 20 vaginal microbes associated with bacterial vaginosis and other conditions; and Explorer™, a health and wellness product to understand the role that food and lifestyle can play in wellness.

uBiome's platform has been used by hundreds of thousands of consumers, patients, and doctors and more than 200 research institutions around the world, including the US Centers for Disease Control (CDC), US National Institutes of Health (NIH), Harvard University, Stanford University, the Massachusetts Institute of Technology (MIT), University of California, San Francisco, Oxford University, and the University of Sydney.

Since its launch, the company has received widespread recognition including CNN 10: Startups to Watch, the IVY Technology Award, CNN Future 30, and was named one of Fast Company's Most Innovative Companies in Healthcare in 2016 and in Data Science in 2018, as well as a Technology Pioneer from the World Economic Forum in 2018. For more information, visit http://www.uBiome.com.

 

SOURCE Ubiome

PR Newswire
www.prnewswire.com

Last updated on: 05/11/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.